Search the Newsreel

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

The Law Offices of Howard G. Smith are investigating GE HealthCare Technologies Inc. (GEHC) for potential federal securities law violations. This comes after GE HealthCare reported lower-than-expected adjusted earnings per share in Q1 2026 and cut its full-year guidance, attributing the impact to a …

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP is continuing its securities fraud investigation into GE HealthCare Technologies Inc. (GEHC) on behalf of investors who lost money. This follows GE HealthCare's Q1 2026 financial report, which included lowered full-year EPS guidance and a significant stock drop …

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Biogen (BIIB) and Vaxcyte (PCVX)

Analysts have provided insights on several healthcare companies, including GE Healthcare Technologies Inc, Biogen, and Vaxcyte. Citi maintained a Hold rating on GE Healthcare with a $75.00 price target, while Biogen also received a Hold rating from Citi with a $200.00 price target. Vaxcyte …

Rothschild & Co Redburn Adjusts GE Healthcare Technologies Price Target to $96 From $98, Maintains Buy Rating

Rothschild & Co Redburn has adjusted its price target for GE Healthcare Technologies (NASDAQ: GEHC) to $96, down from $98. Despite this slight reduction in the price target, the firm has maintained its "Buy" rating for the company's stock.

GE HealthCare Technologies Inc. stock falls Thursday, underperforms market

GE HealthCare Technologies Inc. (GEHC) saw its stock fall by 2.73% on Thursday, closing at $69.94. This performance was contrary to the broader market trend, as both the S&P 500 Index and the Dow Jones Industrial Average recorded gains. The decline ended a three-day …

GE HealthCare (GEHC) Q2 2026 Earnings Call Transcript

GE HealthCare reported strong Q2 2026 results with robust order growth of 11.1% and a record backlog of $23.9 billion, driven by performance in Pharmaceutical Diagnostics and Advanced Imaging Solutions. Despite this, the Patient Care Solutions segment faced challenges, leading to a decline in …

GEHC Q2 Deep Dive: Product Innovation and Service Strength Propel Growth Amid PCS Challenges

GEHC Q2 Deep Dive: Product Innovation and Service Strength Propel Growth Amid PCS Challenges Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 5.8% year on year to $5.30 billion. Its non-GAAP profit …

GE HealthCare Technologies (GEHC) Looks Re Rated After Strong Q2 And Record Backlog

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. GE HealthCare Technologies (GEHC) is back in focus after its second quarter report highlighted …

GE HealthCare (GEHC) Stock Looks Reasonable On Earnings But Stretched On Fair Value

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. GE HealthCare Technologies stock has climbed 17.1% over the past week, yet the latest …

GE HealthCare Technologies (GEHC) Is Up 17.1% After Raising EPS Guidance And Reporting Record Backlog – Has The Bull Case Changed?

In the past week, GE HealthCare Technologies Inc. reported second-quarter 2026 results showing revenue of US$5,295 million (up from US$5,007 million) and net income of US$561 million (up from US$486 million), alongside raised EPS guidance and the appointment of long-serving finance executive George Newcomb …

GE HealthCare Posts Best Orders Quarter Since 2023 Spinoff, But Payoff Is Deferred To 2027

GE HealthCare achieved its best orders quarter since its 2023 spinoff, primarily driven by its legacy portfolio. Despite this strong performance, CEO Peter Arduini indicated that the full financial benefits of these orders are not expected to materialize until 2027. The article also notes …

Why GE HealthCare (GEHC) Stock Is Trading Up Today

Why GE HealthCare (GEHC) Stock Is Trading Up Today What Happened? Shares of healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) jumped 11% in the afternoon session after the company reported second-quarter 2026 results that surpassed Wall Street's expectations for both revenue and profit. The …

GE HealthCare (GEHC) Stock Price Faces Margin Pressure Despite Solid Q2 Growth

GE HealthCare Technologies Inc. Q2 2026 Earnings Call Summary

GE HealthCare Technologies Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Here's Why GE Healthcare Shares Popped Higher Today

Shares in GE Healthcare (NASDAQ: GEHC) were higher by 12% at around 11 a.m. today on the back of its second-quarter earnings report. It's been a difficult year for the company, but the latest results, particularly the order book, are signaling an improvement ahead. …

Ford, Garmin, GE HealthCare, Clean Harbors And Other Big Stocks Moving Higher On Wednesday

Several major stocks, including Ford, Garmin, GE HealthCare, and Clean Harbors, showed significant gains on Wednesday despite a down day for the broader U.S. stock market. These companies reported better-than-expected quarterly financial results or raised their future guidance, leading to substantial stock price increases. …

GE HealthCare Technologies Releases Q2 2026 Financial Results

GE HealthCare Technologies Inc. announced strong Q2 2026 financial results, with adjusted earnings per share of $1.13, surpassing Wall Street expectations, and revenue of $5.29 billion. This growth was driven by robust demand in diagnostic imaging and patient care solutions, particularly Advanced Imaging Solutions. …

GE HealthCare Technologies (GEHC) Beats Q2 Earnings and Revenue Estimates

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

GE HealthCare Stock Soars After Earnings. Here’s What Drove the Profit Gains.

GE HealthCare Technologies stock experienced a significant jump after the company released better-than-expected second-quarter earnings. This rise provides a measure of relief for investors, as the stock had previously seen a 22% decline this year. The positive earnings report suggests a potential turnaround for …

GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds

GE HealthCare exceeded Wall Street's second-quarter profit estimates due to robust demand for its diagnostic and imaging devices and significant tariff refunds. The company's net income reached $561 million, bolstered by $129 million in tariff repayments following a court ruling against illegally collected duties. …

GE HealthCare beats estimates as orders surge to record high

Investing.com -- GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported second-quarter results before the open on Wednesday, exceeding Wall Street expectations. Adjusted earnings per share came in at $1.13, beating the analyst consensus of $1.04 by $0.09. Revenue reached $5.3 billion, topping the estimate of $5.26 …

GE HealthCare Posts Higher Profit, Revenue on Increased Orders

GE HealthCare Technologies reported higher profit and revenue in the second quarter, driven by an increase in orders. The medical-technology company posted a profit of $561 million, or $1.24 a share, exceeding analyst expectations for adjusted earnings. Its total revenues grew by 5.8% to …

Earnings Flash (GEHC) GE HealthCare Technologies Inc. Reports Q2 Revenue $5.30B, vs. FactSet Est of $5.26B

GE HealthCare Technologies Inc. announced its Q2 revenue reached $5.30 billion, surpassing the FactSet estimate of $5.26 billion. The company also reported an adjusted EPS of $1.13 per share, exceeding the FactSet estimate of $1.04, and raised its fiscal 2026 adjusted EPS outlook to …

GE HealthCare’s (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars

GE HealthCare's (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 5.8% year on year to $5.30 billion. Its non-GAAP profit of $1.13 per share …

GE HealthCare: Q2 Earnings Snapshot

This article provides a brief snapshot of GE HealthCare's Q2 earnings. The content does not elaborate on specific financial details or performance metrics, only indicating that it is an earnings announcement.

GE HealthCare (Nasdaq: GEHC) lifts Q2 revenue 5.7% and reaffirms 2026 outlook

GE HealthCare reported strong Q2 2026 financial results, with revenues increasing 5.7% to $5.3 billion and organic growth of 3.5%. The company achieved a record 11.1% organic orders growth, leading to a backlog of $23.9 billion, and reaffirmed its full-year 2026 guidance, including 3.0%-4.0% …

GE HealthCare's Q2 revenue up 5.7% to $5.3 billion

GE HealthCare reported a significant increase in its Q2 revenue, rising by 5.7% to reach $5.3 billion. This growth indicates a strong financial performance for the company during the quarter.

GE HealthCare posts record orders, $23.9B backlog in Q2

GE HealthCare (NASDAQ: GEHC) reported strong second-quarter 2026 financial results, achieving record organic orders growth of 11.1% and a backlog of $23.9 billion. The company's revenue increased by 5.7% to $5.3 billion, with diluted EPS growing by 16.5% to $1.24. GE HealthCare reaffirmed its …

GE HealthCare Technologies Non-GAAP EPS of $1.13 beats by $0.09, revenue of $5.3B beats by $40M

* GE HealthCare Technologies press release [https://seekingalpha.com/pr/20598885-ge-healthcare-reports-second-quarter-2026-financial-results] (GEHC [https://seekingalpha.com/symbol/GEHC]): Q2 Non-GAAP EPS of $1.13 beats by $0.09. * Revenue of $5.3B (+6.0% Y/Y) beats by $40M. * Revenues of $5.3 billion, up 5.7%, including Organic revenue growth* of 3.5%, driven by Pharmaceutical Diagnostics and …

GE HealthCare reports second quarter 2026 financial results

Revenue growth of 5.7%, and Organic revenue growth* of 3.5% Record organic orders growth of 11.1%, book-to-bill of 1.15 times and backlog of $23.9 billion Net income margin of 10.6% and Adjusted earnings before interest and taxes (EBIT) margin* of 14.2%; diluted earnings per …

Q2 profit hits $561M at GE HealthCare (NASDAQ: GEHC) after Intelerad buy

GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market

GE HealthCare Technologies Inc. GEHC reported second-quarter 2026 adjusted earnings per share (EPS) of $1.13, which beat the Zacks Consensus Estimate of $1.04 by 8.7%. The bottom line increased 6.6% year over year, aided by commercial execution, pricing and productivity gains. GAAP EPS in …

GE Healthcare Technologies Inc (GEHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of GE Healthcare Technologies Inc (GEHC), focusing on its price momentum, support and resistance levels, and performance across various technical indicators and moving averages. The current price momentum score is 2.96, ranking it 190 out of 199 in …

A Look at GE HealthCare Technologies Inc (GEHC) After 4.9% Gain -- GF Value $85.42 vs Price $64.11

GE HealthCare Technologies Inc (GEHC) shares gained 4.9%, opening at $64.11, which is 24.9% below its GF Value™ of $85.42, indicating it is undervalued. The company also has an "Above Average" GF Score™ of 72/100, driven by strong valuation but tempered by moderate financial …

GE HealthCare Technologies Inc. stock rises Tuesday, outperforms market

GE HealthCare Technologies Inc. (GEHC) saw its stock increase by 4.89% to $64.11 on Tuesday, outperforming the broader market. This marked the stock's second consecutive day of gains, occurring during a trading session where both the S&P 500 Index and the Dow Jones Industrial …

GE HealthCare Technologies Q2 2026 Earnings Preview

* GE HealthCare Technologies (GEHC [https://seekingalpha.com/symbol/GEHC]) is scheduled to announce Q2 earnings results on Wednesday, July 29th, before market open. * The consensus EPS estimate is $1.04 [https://seekingalpha.com/symbol/GEHC/earnings/estimates] (-1.9% Y/Y) and the consensus revenue estimate is $5.26B (+5.2% Y/Y). * Over the last 2 …